Page 10 - வால்டர் நாணல் இராணுவம் நிறுவனம் ஆஃப் ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Nigeria, others to begin Lassa fever vaccine clinical trials The Punch Published 29 June 2021 The United States of America has said that a new phase of Lassa fever vaccine clinical trials is set to begin in Nigeria, Liberia and Sierra Leone. This was disclosed in a statement on Monday by the Public Affairs Unit of the United States Diplomatic Mission to Nigeria. According to the statement, the International AIDS Vaccine Initiative was awarded €22.8m by the European and Developing Countries Clinical Trial Partnership and the Coalition for Epidemic Preparedness Innovations to conduct a Phase IIB trial of the IAVI Lassa fever vaccine candidate among adults and children in Nigeria, Liberia and Sierra Leone.

United statesSierra leoneWalter reed army institute of researchClinical research centreVaccine initiativeCountries clinical trial partnershipCoalition for epidemic preparedness innovationsPublic affairs unitUnited states diplomatic missionDeveloping countries clinical trial partnershipEpidemic preparedness innovationsNorth americaLassa fever vaccine efficacyWest africaWalter reed army instituteஒன்றுபட்டது மாநிலங்களில்